AIM1L | Absent in melanoma 1-like | | | | | | Tissue enhanced |
ALDH3A1 | Aldehyde dehydrogenase 3 family, member A1 | Enzymes
| | | | | Tissue enhanced |
ALDH3B2 | Aldehyde dehydrogenase 3 family, member B2 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ALOX15B | Arachidonate 15-lipoxygenase, type B | Cytoskeleton related proteins Enzymes
| | | | | Tissue enhanced |
ANXA8 | Annexin A8 | | | | | | Tissue enhanced |
ANXA8L1 | Annexin A8-like 1 | | | | | | Tissue enhanced |
ANXA8L2 | Annexin A8-like 2 | | | | | | Tissue enhanced |
AQP3 | Aquaporin 3 (Gill blood group) | Blood group antigen proteins Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ARNTL2 | Aryl hydrocarbon receptor nuclear translocator-like 2 | Transcription factors
| | | | | Tissue enhanced |
ATG9B | Autophagy related 9B | Predicted membrane proteins
| | | | | Tissue enhanced |
ATP12A | ATPase, H+/K+ transporting, nongastric, alpha polypeptide | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
BARX2 | BARX homeobox 2 | Transcription factors
| | | | | Tissue enhanced |
C15orf62 | Chromosome 15 open reading frame 62 | Mitochondrial proteins
| | | | | Tissue enhanced |
C1orf110 | Chromosome 1 open reading frame 110 | | | | | | Tissue enhanced |
C1orf116 | Chromosome 1 open reading frame 116 | | | | | | Tissue enhanced |
C2orf54 | Chromosome 2 open reading frame 54 | | | | | | Tissue enhanced |
C3orf67 | Chromosome 3 open reading frame 67 | | | | | | Tissue enhanced |
C6orf132 | Chromosome 6 open reading frame 132 | | | | | | Tissue enhanced |
C9orf169 | Chromosome 9 open reading frame 169 | | | | | | Tissue enhanced |
CALML3 | Calmodulin-like 3 | Plasma proteins RAS pathway related proteins
| | | | | Tissue enhanced |
CD1A | CD1a molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CHAC1 | ChaC, cation transport regulator homolog 1 (E. coli) | | | | | | Tissue enhanced |
CLCA2 | Chloride channel accessory 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
CSTA | Cystatin A (stefin A) | Cancer-related genes Disease related genes Plasma proteins
| | | | | Tissue enhanced |
CXCR2 | Chemokine (C-X-C motif) receptor 2 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CYP4F22 | Cytochrome P450, family 4, subfamily F, polypeptide 22 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
DAPL1 | Death associated protein-like 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
DKK4 | Dickkopf WNT signaling pathway inhibitor 4 | Predicted secreted proteins
| | | | | Tissue enhanced |
DSC2 | Desmocollin 2 | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
DUOX1 | Dual oxidase 1 | Enzymes Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
DUOXA1 | Dual oxidase maturation factor 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
EDN2 | Endothelin 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
ENDOU | Endonuclease, polyU-specific | Predicted secreted proteins
| | | | | Tissue enhanced |
EPHA1 | EPH receptor A1 | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
EPHA2 | EPH receptor A2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins RAS pathway related proteins
| | | | | Tissue enhanced |
EPS8L1 | EPS8-like 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
ESPL1 | Extra spindle pole bodies homolog 1 (S. cerevisiae) | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
EVPLL | Envoplakin-like | | | | | | Tissue enhanced |
FAM25A | Family with sequence similarity 25, member A | | | | | | Tissue enhanced |
FAM46B | Family with sequence similarity 46, member B | Predicted secreted proteins
| | | | | Tissue enhanced |
FAM83D | Family with sequence similarity 83, member D | | | | | | Tissue enhanced |
FMO2 | Flavin containing monooxygenase 2 (non-functional) | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
FOXD1 | Forkhead box D1 | | | | | | Tissue enhanced |
FUT3 | Fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group) | Blood group antigen proteins Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
FUT6 | Fucosyltransferase 6 (alpha (1,3) fucosyltransferase) | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
FZD10 | Frizzled family receptor 10 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GABRP | Gamma-aminobutyric acid (GABA) A receptor, pi | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GJB3 | Gap junction protein, beta 3, 31kDa | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
GJB6 | Gap junction protein, beta 6, 30kDa | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
GNA15 | Guanine nucleotide binding protein (G protein), alpha 15 (Gq class) | Plasma proteins
| | | | | Tissue enhanced |